Kunyu Yang

20PUBLICATIONS

64CO-AUTHORS

Gene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyMolecular targetsInnate immunity

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (20)

Sort by Publication Date:

|Jun 24, 2026

Postoperative anlotinib plus radiotherapy in patients with newly diagnosed, unmethylated O<sup>6</sup>-methylguanine-DNA methyltransferase glioblastoma: A single-arm, phase 2 study.

|Jun 10, 2026

TQB2618 plus penpulimab, alone or in combination with chemotherapy, for recurrent or metastatic nasopharyngeal carcinoma: a multicentre, two-cohort, phase 2 trial.

|Mar 31, 2026

A prospective multicenter trial of deep learning auto-segmentation for organs at risk in thoracic radiotherapy.

Gengmin Niu, Yong Guan, Yifan Zhang

|Mar 18, 2025

Retraction Note: β-Trcp and CK1δ-mediated degradation of LZTS2 activates PI3K/AKT signaling to drive tumorigenesis and metastasis in hepatocellular carcinoma.

Yanwei Lu, Xudong Li, Hongli Liu

|Mar 04, 2025

Macrophage-Derived Itaconate Suppresses Dendritic Cell Function to Promote Acquired Resistance to Anti-PD-1 Immunotherapy.

Xiao Yang, Yue Deng, Ying Ye

|Jan 31, 2025

SMARCB1/INI-1-Deficient sinonasal carcinoma demonstrates a poor prognosis but favorable clinical outcomes after PD-1/PD-L1 inhibitor therapy: A case series.

Shuhan Zhao, Hao Du, Zhanjie Zhang

Pageof 4

Frequent Collaborators

Yajie Sun

Jingshu Meng

Honglin Jin

Xixi Liu

Lu Wen

Shuangbing Xu

Qianyuan He

Gang Wu

Chao Wan

Liangliang Shi

Frequent Collaborators

Yajie Sun

Jingshu Meng

Honglin Jin

Xixi Liu